What is BioQ Pharma?
BioQ Pharma operates at the intersection of pharmaceutical innovation and medical device engineering. The company specializes in transforming traditional infusible medicines into pre-filled, ready-to-use systems that simplify dosing regimens. By focusing on hard-to-administer drugs, BioQ Pharma provides a proprietary platform that enhances safety and administration efficiency. Their business model centers on delivering bespoke, adaptable solutions that offer tangible value to payers, providers, and patients alike. As a commercial-stage entity, the firm has successfully transitioned from research and development to active market deployment, leveraging patented technology to solve long-standing logistical challenges in the infusion therapy sector.
How much funding has BioQ Pharma raised?
BioQ Pharma has raised a total of $53.7M across 5 funding rounds:
Debt
$13.7M
Private Equity
$18.3M
Debt
$15M
Private Equity
$6.3M
Debt
$350K
Debt (2014): $13.7M, investors not publicly disclosed
Private Equity (2015): $18.3M, investors not publicly disclosed
Debt (2016): $15M, investors not publicly disclosed
Private Equity (2017): $6.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in BioQ Pharma
PPP
Public-Private Partnership
Undisclosed Investor
A private equity entity focused on long-term value creation within the healthcare and life sciences sectors.
Undisclosed Investor
A strategic capital partner specializing in the commercialization of innovative pharmaceutical delivery platforms.
What's next for BioQ Pharma?
Looking ahead, the strategic deployment of the $350K will likely focus on scaling manufacturing capabilities and broadening the reach of their delivery systems within the global pharmaceutical market. As the company matures, the focus will shift toward deepening partnerships with pharmaceutical manufacturers to integrate their proprietary technology into a wider array of therapeutic products. This growth phase is expected to prioritize operational excellence and the continued validation of their delivery systems in diverse clinical settings. By maintaining a rigorous focus on safety and simplicity, BioQ Pharma is poised to redefine the standards of infusible medicine delivery, potentially setting a new benchmark for efficiency in the healthcare supply chain.
See full BioQ Pharma company page
